: "targeted cgrp small molecule antagonists for acute migraine therapy."
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.
.
.
china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214).
.